HIV-associated neurocognitive disorder—pathogenesis and prospects for treatment D Saylor, AM Dickens, N Sacktor, N Haughey, B Slusher, M Pletnikov, ... Nature Reviews Neurology 12 (4), 234-248, 2016 | 1003 | 2016 |
The global burden of headache D Saylor, TJ Steiner Seminars in neurology 38 (02), 182-190, 2018 | 337 | 2018 |
Mirtazapine use in human immunodeficiency virus–infected patients with progressive multifocal leukoencephalopathy D Cettomai, JC McArthur Archives of neurology 66 (2), 255-258, 2009 | 138 | 2009 |
Reproducibility of optical coherence tomography in multiple sclerosis D Cettomai, M Pulicken, E Gordon-Lipkin, A Salter, TC Frohman, ... Archives of neurology 65 (9), 1218-1222, 2008 | 115 | 2008 |
Diagnosis and classification of optic neuritis A Petzold, CL Fraser, M Abegg, R Alroughani, D Alshowaeir, R Alvarenga, ... The Lancet Neurology 21 (12), 1120-1134, 2022 | 96 | 2022 |
Global HIV neurology: a comprehensive review KT Thakur, A Boubour, D Saylor, M Das, DR Bearden, GL Birbeck Aids 33 (2), 163-184, 2019 | 94 | 2019 |
Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience CA Mecoli, D Saylor, AC Gelber, L Christopher-Stine Clin Exp Rheumatol 35 (4), 671-673, 2017 | 83 | 2017 |
Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis GS Hiremath, D Cettomai, M Baynes, JN Ratchford, S Newsome, ... Multiple Sclerosis Journal 15 (6), 735-740, 2009 | 83 | 2009 |
Acute encephalitis in the immunocompromised individual D Saylor, K Thakur, A Venkatesan Current opinion in infectious diseases 28 (4), 330-336, 2015 | 63 | 2015 |
Neurobehavioral outcomes in autoimmune encephalitis AK Yeshokumar, E Gordon-Lipkin, A Arenivas, J Cohen, A Venkatesan, ... Journal of neuroimmunology 312, 8-14, 2017 | 59 | 2017 |
Moving on from HAND: why we need new criteria for cognitive impairment in persons living with human immunodeficiency virus and a proposed way forward S Nightingale, AJ Dreyer, D Saylor, M Gisslén, A Winston, JA Joska Clinical Infectious Diseases 73 (6), 1113-1118, 2021 | 55 | 2021 |
A survey of rheumatologists’ practice for prescribing pneumocystis prophylaxis D Cettomai, AC Gelber, L Christopher-Stine The Journal of rheumatology 37 (4), 792-799, 2010 | 54 | 2010 |
Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda D Saylor, G Nakigozi, N Nakasujja, K Robertson, RH Gray, MJ Wawer, ... Neurology 89 (5), 485-491, 2017 | 51 | 2017 |
Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review D García-Azorín, KM Seeher, CR Newton, NU Okubadejo, A Pilotto, ... Journal of neurology 268 (11), 3947-3960, 2021 | 40 | 2021 |
Burnout and resilience among neurosciences critical care unit staff TE Purvis, ... Neurocritical Care 31 (2), 406-410, 2019 | 40 | 2019 |
Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya J Kwasa, D Cettomai, E Lwanya, D Osiemo, P Oyaro, GL Birbeck, ... PloS one 7 (3), e32898, 2012 | 36 | 2012 |
Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya J Kwasa, D Cettomai, E Lwanya, D Osiemo, P Oyaro, GL Birbeck, ... PloS one 7 (3), e32898, 2012 | 36 | 2012 |
Comparative Outcomes in Children and Adults With Anti-N-Methyl-D-Aspartate (anti-NMDA) Receptor Encephalitis E Gordon-Lipkin, AK Yeshokumar, D Saylor, A Arenivas, JC Probasco Journal of child neurology 32 (11), 930-935, 2017 | 35 | 2017 |
Neurologic complications of human immunodeficiency virus infection D Saylor CONTINUUM: Lifelong Learning in Neurology 24 (5), 1397-1421, 2018 | 34 | 2018 |
Evidence for the importance of vitamin D status in neurologic conditions AK Yeshokumar, D Saylor, MD Kornberg, EM Mowry Current treatment options in neurology 17, 1-13, 2015 | 31 | 2015 |